Premium
CAN BASELINE PET‐CT FEATURES PREDICT OUTCOMES IN ADVANCED HODGKIN LYMPHOMA? A PROSPECTIVE EVALUATION OF UK PATIENTS IN THE RATHL TRIAL (CRUK/07/033)
Author(s) -
Pike L.C.,
Kirkwood A.A.,
Patrick P.,
Radford J.,
Burton C.,
Stevens L.,
CliftonHadley L.,
Johnson P.W.,
Barrington S.F.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_18
Subject(s) - abvd , medicine , nuclear medicine , hodgkin lymphoma , dacarbazine , hodgkin's lymphoma , stage (stratigraphy) , lymphoma , chemotherapy , vincristine , cyclophosphamide , paleontology , biology